Professors Chris Rowe (ADNeT) and Michael Woodward (Austin Health) will be presenting this interesting one-hour webinar on
- The clinical value of amyloid PET or CSF and forthcoming P-tau blood tests in the diagnosis of cognitive decline.
- How to access the ADNeT Screening for Trials program to obtain free amyloid PET and direct your patients to the most appropriate clinical trial.
- The benefits for memory participating in research into cognitive disorders and their treatment.
- Important treatment trials currently recruiting.